FDANonrulemakingFDA-2019-D-0298

Who commented on this docket

Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry

2 organizations filed 2 public comments on Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry, at the Food and Drug Administration. The comment window closed 2542d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 2542d ago

Abstract

OPEN

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.